HCAT
Health Catalyst Inc

814
Mkt Cap
$181.07M
Volume
625,411.00
52W High
$8.00
52W Low
$2.02
PE Ratio
-1.55
HCAT Fundamentals
Price
$2.46
Prev Close
$2.56
Open
$2.56
50D MA
$2.81
Beta
1.65
Avg. Volume
801,078.68
EPS (Annual)
-$1.15
P/B
0.52
Rev/Employee
$204,389.33
Loading...
Loading...
News
all
press releases
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) General Counsel Benjamin Landry sold 27,425 shares of Health Catalyst stock in a transaction on Friday, December 5th. The shares were sold at an...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) Director Julie Larson-Green sold 47,997 shares of Health Catalyst stock in a transaction dated Thursday, December 4th. The stock was sold at an...
MarketBeat·3d ago
News Placeholder
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has been assigned an average recommendation of "Hold" from the fourteen brokerages that are currently covering the firm, Marketbeat Ratings...
MarketBeat·8d ago
News Placeholder
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder...
PR Newswire·11d ago
News Placeholder
Health Catalyst, Inc. $HCAT Shares Acquired by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. boosted its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 53.6% in the second quarter, according to its most recent disclosure with...
MarketBeat·27d ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) Price Target Lowered to $3.25 at Citigroup
Citigroup cut their price target on shares of Health Catalyst from $3.50 to $3.25 and set a "neutral" rating on the stock in a report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Stifel Nicolaus Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price
Stifel Nicolaus dropped their price target on Health Catalyst from $4.50 to $3.75 and set a "hold" rating for the company in a research note on Tuesday...
MarketBeat·1mo ago
News Placeholder
Wells Fargo & Company Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $5.00
Wells Fargo & Company dropped their price target on Health Catalyst from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) Releases Quarterly Earnings Results, Misses Estimates By $0.09 EPS
Health Catalyst (NASDAQ:HCAT - Get Free Report) released its earnings results on Monday. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of $0.05 by...
MarketBeat·1mo ago
News Placeholder
Health Catalyst (HCAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·1mo ago

Latest HCAT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.